⌘K

Login Start Free

Home/Filings/4/0001140361-16-075795

4//SEC Filing

CytomX Therapeutics, Inc. 4

Accession 0001140361-16-075795

$CTMXCIK 0001501989operating

View on SEC.gov Company Profile

Filed

Aug 10, 8:00 PM ET

Accepted

Aug 11, 12:29 PM ET

Size

19.6 KB

Accession

0001140361-16-075795

Insider Transaction Report

Form 4

Period: 2016-08-09

CytomX Therapeutics, Inc.CTMX

GLUCK FREDERICK W

Director

Transactions

Exercise/Conversion
Common Stock
2016-08-09$1.45/sh+27,606$39,998→ 223,776 total
Exercise/Conversion
Stock Option (right to buy)
2016-08-09−16,612→ 0 total
Exercise: $0.94Exp: 2023-02-25→ Common Stock (16,612 underlying)
Exercise/Conversion
Stock Option (right to buy)
2016-08-09−17,139→ 0 total
Exercise: $1.57Exp: 2025-02-08→ Common Stock (17,139 underlying)
Exercise/Conversion
Common Stock
2016-08-09$0.94/sh+16,612$15,698→ 196,170 total
Exercise/Conversion
Common Stock
2016-08-09$1.57/sh+17,139$26,992→ 240,915 total
Exercise/Conversion
Stock Option (right to buy)
2016-08-09−31,767→ 0 total
Exercise: $1.13Exp: 2021-03-23→ Common Stock (31,767 underlying)
Exercise/Conversion
Stock Option (right to buy)
2016-08-09−27,606→ 0 total
Exercise: $1.45Exp: 2024-05-23→ Common Stock (27,606 underlying)
Exercise/Conversion
Common Stock
2016-08-09$1.13/sh+31,767$36,021→ 179,558 total

Holdings

Common Stock
(indirect: By Trust)
331,643
Common Stock
(indirect: By Spouse)
3,200
Common Stock
(indirect: By LLC)
22,111

Footnotes (3)

[F1]The Reporting Person is a trustee of Frederick W. Gluck 1997 Family Trust dtd July 28, 1997.
[F2]Richlin Partners, LLC is an entity owned of record by the spouse of the Reporting Person.
[F3]100% of the shares subject to the option are fully vested and exercisable.

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

CytomX Therapeutics, Inc.

CIK 0001501989

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001501989

Filing Metadata

Form type: 4
Filed: Aug 10, 8:00 PM ET
Accepted: Aug 11, 12:29 PM ET
Size: 19.6 KB

View on SEC.gov